GSK872 is a specific RIPK3 inhibitor. It affects MAPK and NF-kB signaling by blocking RIPK3 activation to inhibit necroptosis.
GSK872 MOA:Targeting RIPK3/Necroptosis Pathway for Neurodegenerative Diseases
GSK872 is a specific RIPK3 inhibitor. It affects MAPK and NF-kB signaling by blocking RIPK3 activation to inhibit necroptosis.